SCHEMBL2225100

SCHEMBL2225100

NS(=O)(=O)c1ccc(OC(F)(F)F)c(CNc2cc(Nc3ccc(F)c(F)c3)ncn2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 3/20 0.48
BCR P11274 3/20 0.48
TNNI3K Q59H18 3/20 0.47
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNA2 P20248 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
SOS1 Q07889 2/20 0.44
EGFR P00533 2/20 0.43
ERBB3 P21860 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 3/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 1/20 0.40
KDR P35968 1/20 0.39
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2226257 0.90 TNNI3K (0.49) ABL1BCRTNNI3KCDK1CCNB1
SCHEMBL2225574 0.90 TNNI3K (0.59) ABL1BCRTNNI3KCDK1CCNB1
SCHEMBL2227178 0.83 TNNI3K (0.61) ABL1BCRTNNI3KCDK1CCNB1
SCHEMBL2225414 0.82 CDK1 (0.46) ABL1BCRTNNI3KCDK1CCNB1
SCHEMBL2227241 0.81 CDK1 (0.46) ABL1BCRTNNI3KCDK1CCNB1
SCHEMBL2228424 0.80 TNNI3K (0.61) ABL1BCRTNNI3KCDK1CCNB1
SCHEMBL2224948 0.78 TNNI3K (0.51) ABL1BCRTNNI3KCDK1CCNB1
SCHEMBL2227311 0.77 TNNI3K (0.61) TNNI3KCDK1CCNB1CCNA2CCNE1
SCHEMBL2226458 0.77 TNNI3K (0.49) ABL1BCRTNNI3KCDK1CCNB1
SCHEMBL2225585 0.77 EGFR (0.54) TNNI3KCDK1CCNB1CCNA2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed